LITERATUR

Literaturauswahl

1. Aberer E, Kersten A, K\ade H, Poitschek C,Jurecka W (1996):
Heterogenety of Borrelia burgdorferi in the skin
Am J Dermatopathol, 1996, 18, 571-5792.

2. Aberer E, Koszik F, Silberer M (1997):
Why is chronic Lyme borreliosis chronic?
Clin Infect Dis, 1997, 25, 1, 64-70

3. Ackermann R (1983):
Erythema chronicum migrans und durch Zecken übertragene Meningopolyneuritis (Garin-Bujadoux-Bannwarth) Borrelien-Infektionen? [Chronic erythema migrans and tick-transmitted Meningopolyneuritis (Garin-Bujadoux-Bannwarth): Borrelia infections?]
Dtsch Med Wochenschrift, 1983, 108, 577-580

4. Ackermann R, Rhese-Kupper B, Gollmer E (1986):
Progressive Borrelia Encephalomyelitis
Zentralbl Bakteriol, 1986, 263, 297-300

5. Ackermann R, Boisten HP, Kabaszki J, Steere AC, Grodzick RL, Hartung S, Runne U (1984):
Spirochäten-Ätiologie der Erythema-chronicum-migrans-Krankheit
Dtsch Med Wochenschrift, 1984, 109, 92-97

6. Ackermann R, Gollmer E, Rehse-Küpper B (1985):
Progressive Borrelien-Encephalomyelitis
Dtsch Med Wochenschrift, 1985, 26, 1039-1042

7. Afzelius A (1910):
Verhandlungen der dermatologischen Gesellschaft zu Stockholm, 16. Dezember 1909,
Arch Dermatol Syph, 1910, 101, 405-406

8. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP (1993):
Serodiagnosis in early Lyme disease
J Clin Microbiol, 1993, 31, 12, 3090-3095

9. Aktories K, Förstermann U, Hofmann FB, Starke K (2001)
Endotoxine n: Allgemeine und spezielle Pharmakologie und Toxikologie
Elsevier, Urban & Fischer, 8. Auflage, 2001, 1090

10. Asbrink E (1991):
Cutaneous manifestations of Lyme borreliosis. Clinical definitions and differential diagnoses
Scand J Infect Dis, 1991, 77, 44-50

11. Asbrink E, Hovmark A (1985):
Successful cultivation of spirochetes from skin lesions of patients wirh erythema chronicum migrans Afzelius
Acta Pathol Microbiol Immunol Scand, B, 1985, 93, 161-163

12. Asbrink E, Olsson I, Hovmark A (1986):
Erythema chronicum migrans Afzelius in Sweden. A study on 231 patients
Zentralbl Bakteriol Mikrobiol Hyg [A], 1986, 263, 1-2, 229-236

13. Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A, (1994):
Lyme disease: an infectious and post infectious syndrome
J Rheumatol, 1994, 21, 454-456

14. Atlas E, Novak SN, Duray PH, Steere AC (1988):
Lyme myositis: muscle invasion by Borrelia burgdorferi,
Ann Intern Med, 1988, 109, 3, 245-246

15. Atlas RM (1997):
Principles of Microbiology
2. ed, Wm. C. Brown (1997)

16. Baehr R (2001):
Der Lymphozytentransformationstest für Borrelien: Neue diagnostische Möglichkeiten für Problemfälle,
Informationsveranstaltung Borreliose Selbsthilfe e.V. 17.0.2001, St. Marien-Krankenhaus in Berliun-Lankwitz

17. Balmelli T, Piffaretti JC (1995):
Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato
Res Microbiol, 1995, 146, 329-340

18. Bannwarth A (1941):
Chronische lymphozytäre Meningitis, entzündliche Polyneuritis und „Rheumatismus“ Ein Beitrag zum Problem „Allergie und Nervensystem“ in zwei Teilen
Arch Psychiatr Nervenkr, 1941, 113, 284-376

19. Barbour A, Hayes SF (1986):
Biology of Borrelia species
Microbiol Rev, 1986, 50, 381-400

20. Barbour A, Schrumpf ME (1986):
Polymorphisms of major surface proteins of Borrelia burgdorferi
Zentralbl Bakteriol, 1986, 263, 83-91

21. Barbour AG (1984):
Isolation and cultivation of Lyme disease spirochetes
Yale J Biol Med, 1984, 57, 521-525

22. Barbour AG, Fish D (1993):
The biological and social phenomenon of Lyme disease
Science, 1993, 260, 5114, 1610-1616

23. Barbour AG, Garon CF (1988):
The genes encoding major surface proteins of Borrelia Burgdorferi are located on a plasmid
Ann NY Acad Sci, 1988, 539, 144-153

24. Barker IK, Surgeoner GA, McEwen SA, Artsob H (1989)
Distribution of the Lyme disease agent in wildlife reservoirs in Ontario
Can Dis Wkly Rep, 1989, 15, 27, 141-142

25. Bartak P, Hulinska D (1997)
Apoptosis in the morphology of Lyme borreliosis
Cas Lek Cesk, 1997, 136, 5, 146-147

26. Bartunek P, Mrazek V, Gorican K, Bina R, Listvanova S, Zapletalova J (2001):
Borrelia infection as a cause of carditis (a long-term study)
Wien Klin Wochenschr, 2001, 113, 1-2, 38-44

27. Bauer, Y, (1999):
Untersuchungen zur zellulären Immunantwort bei der Borrelia burgdorferi-Infektion
Disseration Medizinische Fakultät der Ruprecht-Karls-Universität

28. Bauer Y, Hofmann H, Jahraus O, Mytilineos J, Simon MM, Wallich R, (2001):
Prominent T cell response to a selectively in vivo expressed Borrelia burgdorferi outer surface protein (pG) in patients with Lyme disease
Eur J Immunol, 2001, 31, 3, 767-776

29. Beermann C, Lochnit G, Geyer R, Groscurth P, Filgueira L (2000):
The lipid component of lipoproteins from Borrelia burgdorferi: Structural analysis, antigenicity, and presentation via human dendritic cells
Biochem Biophys Res Comm, 2000, 267, 897-905

30. Bergström S, Bundoc VG, Barbour AG (1989):
Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochete Borrelia burgdorferi
Mol Microbiol, 1989, 3, 479-486

31. Binder E, Doepfmer R, Hornstein OP (1955):
Übertragung des Erythema chronicum migrans von Mensch zu Mensch in 2 Passagen
Klin Wochenschr, 1955, 33, 727-728

32. Brade V, Kleber I, Acker G (1992):
Differences of two Borrelia burgdorferi strains in complement activation and serum resistance
Immunobiol, 1992, 185, 453-465

33. Bradley JF, Johnson RC, Goodman JL (1994):
Ann Intern Med, 1994, 120, 487-489

34. Brandt ME, Riley BS, Radolf JD, Norgard MV (1990):
Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins
Infect Immun, 1990, 58, 983-991

35. Brorson 0, Brorson SH (1998):
In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid and transformation to mobile spirochetes by incubation in BSK-H medium
Infection, 1998, 26, 144-150

36. Brorson O, Brorson SH (1998)
A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes
APMIS, 1998, 106, 12, 1131-1141

37. Brorson O, Brorson SH, Henriksen TH, Skogen PR, Schoyen R (2001):
Association between multiple sclerosis and cystic structures in cerebrospinal fluid
Infection 2001, 29, 6, 315-319

38. Bujak DI, Weinstein A, Dornbush RL, (1996):
Clinical and neurocognitive features of the post Lyme syndrome
J Rheumatol 1996, 23, 1392-1397

39. Burgdorfer W, Barbour A, Hayes SF, Benach J, Grunwald E and Davis JP (1982):
Lyme disease - a tick-borne spirochetosis?
Science, 1982, 216, 1317-1319

40. Burgdorfer W, Hyes SF, Corwin D, (1989):
Pathophysiology of the Lyme disease spirochete Borrelia burgdorferi in Ixodes ticks
Rev Infect Dis , 1989, 11, 6, 1442-1450

41. Burgdorfer W, Lane RS, Barbour AG, Gresbrink RA, Anderson JF (1985):
The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi
Am J Trop Med Hyg, 1985, 34, 925-930

42. Busch U, Hizo-Teufel C, Boehmer R, Fingerle V, Nitschko H, Wilske B, Preac-Mursic V (1996):
Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR',
J Clin Microbiol, 1996, 34, 5, 1072-1078

43. Carroll J, Gherardini FC (1996):
Membrane protein variations associated with in vitro passage of Borrelia burgdorferi
Infect Immun, 1996, 64, 392-398

44. Carroll JA, Garon CF, Schwan TG (1999):
Effects of environmental pH on membrane proteins in Borrelia burgdorferi
Infect Immun, 1999, 67, 7, 3181-3187

45. Cartwright MJ, Martin SE, Donata ST (1999):
A novel neurotoxin (Bbtox 1) Borrelia burgdorferi
Meeting of the American Society for Microbiology, Chicago, May 1999

46. Casjens S, Murphy M, DeLange M, Sampson L, van Vugt R, Huang WM (1997):
Telomeres of the linear chromosomes of Lyme disease spirochaetes: nucleotide sequence and possible exchange with linear plasmid telomeres
Mol Microbiol, 1997, 26, 3, 581-596

47. Chavanet P, Pillon D, Lancon JP, Waldner-Combernoux A, Maringe E, Portier H (1987)
Granulomatous hepatitis associated with Lyme disease',
Lancet, 1987, 2, 8559, 623-624

48. Christen HJ, Hanefeld F, Eiffert H, Thomssen R (1993):
Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis
Acta Paediatr, 1993, 386, 1-75

49. Cimmino MA, Azzolini A, Tobia F, Pesce CM (1988):
Spirochetes in the spleen of a patient with chronic Lyme disease
Am J Clin Pathol, 1988, 91, 1, 95-97

50. Cinco M, Rusciao M, Rapagna F (2000):
Evidence of Dbps (decorin binding proteins) among European strains of Borrelia burgdorferi sensu lato and in the immune response of LB patient sera
FEMS Microbiol Lett, 2000, 183, 1, 111-114

51. Coleman J, Sellati TJ, Testa JE, Kew RR, Furie MB, Benach JL (1995):
Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers
Infect Immun, 1995, 63, 2478-2484

52. Coleman JL, Benach JL (1987):
Isolation of antigenetic components form the Lyme disease spirochete: Their role in early diagnosis
J Infect Dis, 1987, 155, 756-765

53. Coleman JL, Roemer EJ, Benach JL (1999):
Plasmin-coated borrelia Burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix
Infect Immun, 1999, 67, 8, 3929-3936

54. Coyle PK, Belman AL, Krupp LB (1992):
B. burgdorferi-specific immune complexes in cerebrospinal fluid
Abstr. 167, p. A29. Program Abstr. 5th Conf. Lyme Borreliosis. 1992

55. Coyle PK (1997):
Borrelia burgdorferi infection: clinical diagnostic techniques / Borrelia burgdorferi Infektion: Klinische diagnostische Techniken
Immunological Investigations 1997, 26, 1&2, 117-128

56. Dattwyler R, Volkman D, Luft B, Halperin AJ (1987):
Lyme disease in Europe and North America
Lancet, 1987, 1, 681

57. Dattwyler RJ, Thomas JA, Benach JL, Golightly MG (1986):
Cellular immune response in Lyme disease: the response to mitogens, live Borrelia burgdorferi, NK cell function and lymphocyte subsets.
Zbl Bakt Hyg A, 1986, 263, 151-159

58. Dattwyler RJ, Volkman DJ, Halperin JJ, Luft BJ, Thomas J, Golightly MG (1988):
Specific Immune Responses in Lyme Borreliosis. Characterization of T Cell and B Cell Responses to Borrelia burgdorferi
Ann NY Acad Sci, 1988, 539, 93-102

59. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin MD, Thomas J, Golightly MG (1988):
Seronegative Lyme disease
New Engl J Med, 1988, 319, 1441-1446

60. De Saint-Vis B, Fugier-Vivier I, Massacrier C, Gaillard C, Vanbervliet B, Ait-Yahia S, Banchereau, Liu YJ, Lebecque S, Caux C (1998):
The Cytokine Profile Expressed by Human Dendritic Cells Is Dependent on Cell Subtype and Mode of Activation
J Immunol, 1998, 160, 1666-1676

61. De Silva A, Telford SR, Brunet LR, Barthold SW, Fikrig E (1996):
Borrelia burgdorferi OspA is an anthropod-specific transmission-blocking Lyme disease vaccine
J Exp Med, 1996, 183, 271-275

62. Defosse DL, Johnson RC (1992):
In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi
Infect Immun, 1992, 60, 3, 1109-1113

63. Ditton HJ, Neuss M, Zoller L (1992):
Evidence that Borrelia burgdorferi immunodominant proteins p100, p94, p83 are identical
FEMS Microbiol Lett 1992, 73, 3, 217-220

64. Dorward DW, Huhuenel ED, Davis G, Garon CF (1992):
Extracellular Borrelia burgdorferi proteins interact with non-borrelia-directed IgM antibodies
Abstr. 219, p. A38. Program Abstr. 5th Int. Conf. Lyme Borreliosis

65. Dorward DW, Schwan TG, Garon CF (1991):
Immune capture and detection of Borrelia burgdorferi antigens in urine, blood, or tissues from infected ticks, mice, dogs, and humans
J Clin Microbiol, 1991, 29, 6, 1162-1170

66. Doyle MK, Telford SR, Criscione L, Lin SR, Spielman A, Gravallese EM (1998):
Cytokines in murine Lyme carditis: Th1 cytokine expression follows expression of proinflammatory cytokines in a susceptible mouse strain
J Inf Dis, 1998, 177, 242-246

67. Dressler F, Yoshinari NH, Steere AC (1991):
The T-Cell proliferative assay in diagnosis of Lyme disease
Ann Intern Med, 1991, 115, 533-539

68. Duray PH (1992):
Target organs of Borrelia burgdorferi infections: functional responses and histology
11-30

69. Duray PH (1989):
Clinical pathologic correlations of Lyme disease
Rev Infect Dis, 1989, 11, 6, 1487-1493

70. Eiffert H, Karsten A, Thomssen R, Christen HJ (1998):
Characterization of Borrelia burgdorferi strains in Lyme arthritis,
Scand J Infect Dis, 1998, 30, 3, 265-268

71. Fallon BA, Kochevar JM, Gaito A, Nields JA (1998):
The underdiagnosis of neuropsychiatric Lyme disease in children and adults
Psychiatr Clin North Am, 1998, 21, 693-703

72. Feng S, Hodzic E, Stevenson B, Barthold SW (1998):
Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice
Infect Immun, 1998, 66, 86, 2827-2835

73. Fikrig E, Barthold SW, Sun W, Feng W, Telford SR, Flavell RA (1997):
Borrelia burgdorferi p35 and p37 proteins, expressed in vivo, elicit protective immunity
Immunity, 1997, 6, 531-539

74. Fikrig E, Liu B, Fu LL, Das S, Smallwood JI, Flavell RA, Persing DH, Schoen RT, Barthold SW, Malawista SE (1995):
An ospA frame-shift, identified from DNA in Lyme arthritis synovial fluid, results in an outer surface protein A that does not bind protective antibodies
J Immunol, 1995, 155, 5700-5704

75. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK, Gwinn M, Dougherty B, Tomb JF, Fleischmann RD, Richardson D, Peterson J, Kerlavage AR, Quackenbush J, Salzberg S, Hanson M, van Vugt R, Palmer N, Adams MD, Gocayne J, Venter JC (1997):
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi
Nature, 1997, 390, 6660, 580-586

76. Fuchs H, Wallich R, Siman MM, Kramer MD (1994):
The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor
Proc Natl Acad Sci USA, 1994, 91, 12594-12598

77. Garcia-Monco JC, Villar BF, Alen JC, Benach JL (1990):
Borrelia burgdorferi in the central nervous system: experimental and clinical evidence for early invasion
J Infect Dis, 1990, 161, 1187-1193

78. Garcia-Monco J, Fernandez-Villar B, Benach JL (1989):
Adherence of the Lyme disease spirochete to glial cells and cells of glial origin
J Infect Dis, 1989, 160, 497-506

79. Garcia-Monco J, Fernandez-Villar B, Rogers RC, Szczepanski A, Wheeler CM, Benach JL (1992):
Borrelia burgdorferi and other related spirochetes bind to galactocerebroside
Neurology, 1992, 42, 1341-1348

80. Garin C, Bujadoux CH (1922):
Paralysie par les tique
J Med Lyon, 1922, 71, 765-767

81. Garon CF, Dorward DW, Corwin MD (1989):
Structural features of Borrelia burgdorferi--the Lyme disease spirochete: silver staining for nucleic acids
Scanning Microsc, 1989, 3, 109-115

82. Gassmann GS, Jacobs E, Deutzmann R, Gobe UB (1991):
Analysis of the fla gene of Borrelia burgdorferi GeHo and antigenic characterization of its gene product
J Bacteriol, 1991, 173, 1452-1459

83. Gassmann GS, Kramer M, Gobel UB, Wallich R (1989):
Nucleotide sequence of a gene encoding the Borrelia burgdorferi flagellin
Nucleic Acids Res, 1989, 17, 3590

84. Gay D, Dick G (1986):
Is multiple sclerosis caused by an oral spirochaete?
Lancet, 1986, 12, 75-81

85. Gerber MA, Zemel LS, Shapiro ED (1998):
Lyme arthritis in children: clinical epidemiology and long-term outcomes
Pediatrics, 1998, 102, 4, 1, 905-908

86. Giambartolomei GH, Dennis VA, Philipp MT (1998):
Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and Rhesus monkeys
Infect Immun, 1998, 66, 6, 2691-2697

87. Gilmore RD, Piesman J (2000):
Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice
Infect Immun, 2000, 68, 1, 411-414

88. Goellner MH, Agger WA, Burgess JH, Duray PH (1988):
Hepatitis due to recurrent Lyme disease
Ann Intern Med, 1988, 108, 5, 707-708

89. Grodzicki RL, Steere AC (1988):
Comparison of immunobloting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease
Inf Dis, 1988, 157, 4, 790-797

90. Guner E (1994):
Retention of B. burgdorferi pathogenicity and infectivity after multiple passages in a co-culture system
Experientia, 1994, 50, 54-59

91. Guner E (1996):
Complement evasion by the Lyme disease spirochete Borrelia burgdorferi grown in host-derived tissue co-culture: role of fibronectin in complement resistance
Experinentia, 1996, 52, 364-372

92. Guo BP, Brown EL, Dorward DW, Rosenberg LC, Hook M (1998):
Decorin-binding adhesins from Borrelia burgdorferi
Mol Microbiol, 1998, 30, 4, 711-723

93. Habicht GS, Katona LI, Benach JL (1991):
Cytokines and the burgdorferi lipopolysaccharide and its role in the pathogenesis of pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6
J Infect Dis, 1991, 164, 568-574

94. Hagman KE, Lahdenne P, Popova TG, Porcella SF, Akins DR, Radolf JD, Norgard MW (1998):
Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and its protective in the murine model of Lyme borreliosis
Infect Immun, 1998, 66, 6, 2674-2683

95. Halperin J, Luft BJ, Volkman DJ, Dattwyler RJ (1990):
Lyme borreliosis: peripheral nervous system manifestations
Brain, 1990, 113, 1207-1211

96. Hansen K, Bangsborg JM, Fjordvang H, Pedersen NS, Hindersson P (1988):
Immunochemical characterization of an isolation of the gene for a Borrelia burgdorferi immunodominant 60-kilodalton antigen common to a wide range of bacteria
Infect Immun, 1988, 56, 2047-2053

97. Hanson MS, Cassatt DR, Guo BP, Patel NK, McCarthy MP, Dorward DW, Hook M (1998):
Active and passive immunitiy against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection
Infect Immun, 1998, 66, 5, 2143-2153

98. Hardin JA, Steere AC, Malawista SE (1979):
Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity
N Engl J Med, 1979, 301, 1358-1363

99. Hartmann F, Müller-Marienburg H, Hopf-Seidel P (2004):
Über die Cholestyramintherapie der chronischen Borreliose
medizin 2000 plus, 2004, 1, 14-19

100. Hauser U, Lehnert G, Wilske B (1999):
Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe
J Clin Microbiol, 1999, 37, 7, 2241-2247

101. Hauser U, Lehnert G, Lobentanzer R, Wilske B (1997):
Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato
J Clin Microbiol, 1997, 35, 6, 1433-1444

102. Hellerström S (1930):
Erythema chronicum migrans Afzelii
Acta derm Venereol (Stockh), 1930, 11, 315-321

103. Herxheimer, K and Hartmann, K (1902):
Über Acrodermatitis chronica atrophicans
Arch Dermatol Syph, 1902, 61, 57-76

104. Herzer P, Wilske B, Preac-Mursic V, Schierz G, Schattenkirchner M, Zollner N (1986)
Lyme arthritis: clinical features, serological, and radiographic findings of cases in Germany
Klin Wochenschr, 1986, 64, 5, 206-215

105. Hofmann H (1996):
Lyme borreliosis - Problems of serological diagnosis
Infection, 1996, 24 , 6, 470-472

106. Hu L, Perides G, Noring R, Klempner MS (1995):
Binding of human plasminogen to Borrelia burgdorferi
Infect Immun, 1995, 63, 491-496

107. Huppertz HI, Mösbauer S, Busch DH, Karch H (1996):
Lymphoproliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents
Eur J Pediatr, 1996, 155, 297-302

108. Hyde FW, Johnson RC, White TJ, Shelburne CE (1989):
Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease
J Clin Microbiol, 1989, 27, 58-61

109. Isaacs R (1994):
Borrelia burgdorferi bind to epithelial cell proteoglycans
J Clin Invest, 1994, 93, 809-819

110. Isogai E, Kimura K, Fujii N, Nishikawa T, Ishii N, Postic D, Baranton G, Isogai H (1996):
Platelet-activating factor-mediated pathogenesis in Lyme disease
Infect Immun, 1996, 60, 1026-1029

111. Issakainen J, Gnehm HE, Lucchini GM, Zbinden R (1996):
Value of clinical symptoms, intrathecal specific antibody production and PCR in CSF in the diagnosis of childhood Lyme neuroborreliosis
Klin Padiatr, 1996, 208, 3, 106-109

112. Jauris-Heipke S, Fuchs R, Motz M, Preac-Mursic V, Schwab E, Soutschek E, Will G, Wilske B (1993):
Genetic heterogenity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi
Med Microbiol Immunol (Berl), 1993, 182, 1, 37-50

113. Jauris-Heipke S, Rossle B, Wanner G, Habermann C, Rossler D, Fingerle V, Lehnert G, Lobentanzer R, Pradel I, Hillenbrand B, Schulte-Spechtel U, Wilske B (1999):
Osp17, a novel immunodominant outer surface protein of Borrelia afzelii: recombinant expression in Escherichia coli and its use as a diagnostic antigen for serodiagnosis of Lyme borreliosis
Med Microbiol Immunol (Berl), 1999, 187, 4, 213-219

114. Jungblut PR, Zimny-Arndt U, Zeindl-Eberhart E, Stulik J, Koupilova K, Pleissner KP, Otto A, Muller EC, Sokolowska-Kohler W, Grabher G, Stoffler G (1999):
Proteomics in human disease: cancer, heart and infectious diseases
Electrophoresis, 1999, 20, 10, 2100-2110

115. Kaplan RF, Meadows ME,Vincent LC Logigian EL, Steere AC (1992):
Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients
Neurology, 1992, 42, 1263-1267

116. Karch H, Huppertz HI, Bohme M, Schmidt H, Wiebecke D, Schwarzkopf A (1994):
Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies
J Clin Microbiol, 1994, 32, 2312-2314

117. Katona LI, Beck G Habicht GS (1992):
Purification and immunological characterization of a major low-molecular-weight lipoprotein from Borrelia burgdorferi
Infect Immun, 1992, 60, 4995-5003

118. KellerTL, Halperin JJ, Whitman M (1992):
PCR detection of Borrelia burgdorferi DNA in cerobrospinal fluid of Lyme neuroborreliosis patients
Neurology, 1992, 42, 32-42

119. Klempner MS, Noring R, Rogers RA (1993):
Invasion of human skin fibroblasts by the Lyme disease spirochete Borrelia burgdorferi
J Infect Dis, 1993, 167, 1074-1081

120. Knigge H, Simon MM, Meuer SC, Dramer MD, Wallich R (1996):
The outer surface lipoprotein OspA of Borrelia burgdorferi provides co-stimulatory signals to normal human peripheral CD4+ and CD8+ T lymphozytes
Eur J Immunol, 1996, 26, 2299-2303

121. Kopp P, Schmitt M, Wellensiek HJ, Bolbel H (1995):
Isolation and characterization of fibronectin-binding sites of Borreilia garinii N34
Infect Immun, 1995, 63, 3804-3808

122. Kristoferitsch W (1993):
Neurologic manifestations in Lyme borreliosis
Clin Dermatol, 1993, 11, 3, 393-400

123. Krupp LB, Masur D, Schwartz D, Coyle P, Langenbach LJ, Fernquist SK, Jandorf L, Halperin J (1991):
Cognitive functioning in late Lyme borreliosis
Arch Neurol, 1991, 48, 1125-1129

124. Lam TT, Nguyen TP, Montgomery RR, Kantor FS, Fikrig E, Flavell RA (1994):
Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease
Infect Immun, 1994, 62, 290-298

125. Lefebvre RB, Perng GC, Johnson RC (1990):
The 83-kilodalton antigen of Borrelia burgdorferi which stimulates immunoglobulin M (IgM) and IgG responses in infected hosts is expressed by a chromosomal gene
J Clin Microbiol, 1990, 28, 7, 1673-1675

126. Lesser RL (1995):
Ocular manifestations of Lyme Disease
Am J Med, 1995, 98, 4A, 605-625

127. Liegner KB, Dorward DW, Garon CF (1992):
Lyme borreliosis (LB) studied with the Rocky Mountain Laboratory (RML) antigen-capture assay in urine
Abstr. 104, p. A18. Program Abstr. 5th Int. Conf. Lyme Borreliosis, 1992

128. Lipschütz B (1913):
Über eine seltene Erythemform (Erythema chronicum migrans)
Arch Derm Syph (Berl), 1913, 118, 349-356

129. Luft BJ, Steinman CR, Neimark HC, Muralidhar B, Rush T, Finkel MF, Kunkel M, Dattwyler RJ (1992):
Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection
JAMA, 1992, 267, 10, 1364-1367

130. Ma Y, Seiler KP, Tai KF, Yang L, Woods M, Weis JJ (1994):
Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the
cytokine-inducible pathway
Infect Immun, 1994, 62, 3663-3671

131. Ma Y, Weis JJ (1993):
Borrelia burgdorferi Outer Surface Lipoproteins OspA and OspB Posses B-Cell Mitogenic and Cytokine-Stimulatory Properties
Infect Immun, 1993, 61, 9, 3843-3853

132. Malawista SE (1989):
Lyme disease: Pathogenesis of Lyme disease
Rheumatol Int, 1989, 9, 233-235

133. Marconi R, Samuels DS, Schwan TG, Garon CF (1993):
Identification of a protein in several Borrelia species which are related to OspC or Lyme disease spirochetes
J Clin Microbiol, 1993, 31, 2577-2583

134. Marcus LC, Steere AC, Duray PH, Anderson AE, Mahoney EB (1985):
Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium
Ann Intern Med, 1985, 103, 3, 374-6

135. Marshall V (1988):
Multiple sclerosis is a chronic central nervous system infection by a spirochetal agent
Med Hypoth, 1988, 25, 89-92

136. Martin R, Ortlauf J, Sticht-Groh V, Bogdahn U, Goldmann SF, Mertens HG (1988):
Borrelia burgdorferi-specific and autoreactive T-Cell Lines from cerebrospinal fluid in Lyme radiculomyelitis
Ann Neurol, 1988, 24, 509-516

137. Massarotti EM, Luger SW, Rahn DW, Messner RP, Wong JB, Johnson RC, Steere AC (1992):
Treatment of early Lyme disease
Am J Med, 1992, 92, 4, 396-403

138. Mathiesen MJ, Christiansen M, Hansen K, Holm A, Asbrink E, Theisen M (1998):
Peptide-based OspC enzyme-linkes immunosorbent assay for serodiagnosis of Lyme borreliosis
J Clin Microbiol, 1998, 36, 12, 3474-3479

139. McAlister HF, Klementowicz PT, Andrews C, Fisher JD, Feld M, Furman S (1989):
Lyme carditis: an important cause of reversible heart block
Ann Intern Med, 1989, 110, 339-345

140. MIQ-Expertengremium der DGHM (2000)
Qualitätsstandards Lyme Borreliose
Urban & Fischer Verlag 2000

141. Modolell M, Schauble UE, Rittig M, Simon MM (1994):
Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete
Immunol Lett, 1994, 40, 139-146

142. Moffat CM, Sigal LH, Steere AC, Freeman DH, Dwyer JM (1984):
Cellular immune findings in Lyme disease: Correlation with serum IgM and disease activity
Am J Med, 1984, 77, 625-632

143. Moter SE, Hofmann H, Wallich R, Simon MM, Kramer MD (1994):
Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR
J Clin Microbiol, 1994, 32, 2980-2988

144. Murgia R, Marchetti F, Cinco M (1999)
Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato
Antimicrob Agents Chemother, 1999, 43, 12, 3030-3032

145. Murgia R, Piazzetta C, Cinco M (2002)
Cystic forms of Borrelia burgdorferi sensu lato: induction, development, and the role of RpoS
Wien Klin Wochenschr, 2002, 114, 13-14, 574-579

146. Nadelman RB, Wormser GP (1998):
Lyme borreliosis
Lancet, 1998, 352, 9127, 557-565

147. Obonyo M, Munderloh UG, Fingerle V, Wilske B, Kurtti TJ (1999):
Borrelia burgdorferi in tick cell culture modulates expression of outer surface proteins A and C in repsonse to temperature
J Clin Microbiol, 1999, 37, 7, 2137-2141

148. O'Connell S, Granstrom M, Gray JS, Stanek G (1998):
Epidemiology of European Lyme borreliosis
Zentralbl Bakteriol, 1998, 287, 3, 229-240

149. Pfister HW, Neubert U, Wilske B, Preac-Mursic V, Einhäupl KM, Borasio GD (1986):
Reinfection with Borrelia burgdorferi
Lancet II, 1986, 984-985

150. Pohl-Koppe A, Kaunicnik A, Wilske B (2001):
Characterization of the cellular and humoral immune response to outer surface protein C and outer surface protein 17 in children with early disseminated Lyme borreliosis
Med Microbiol Immunol (Berl), 2001, 189, 4, 193-200

151. Pollack RJ,Telford SR, Spielman A (1993):
Standardization of medium for culturing Lyme disease spirochetes
J Clin Microbiol, 1993, 31, 1251-1255

152. Preac-Mursic V, Pfister HW, Spiegel H, Burk R, Wilske B, Reinhardt S, Bohmer R (1993):
First isolation of Borrelia burgdorferi from an iris biopsy
J Clin Neuroophthalmol, 1993, 13, 3, 155-161, discussion 162

153. Preac-Mursic VP, Wanner G, Reinhardt S, Wilske B, Busch U, Marget W (1996)
Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants
Infection, 1996, 24, 3, 218-226

154. Preac-Mursic V, Wilske B, Schierz G (1986):
European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility
Zentralbl Bakteriol Mikrobiol Hyg [A], 1986, 263, 1-2, 112-118

155. Preac-Mursic V, Wilske B, Herzer P, Schierz G, Bauer M (1985):
Acrodermatitis chronica atrophicans--a borreliosis
Hautarzt, 1985, 36, 12, 691-693

156. Preac-Mursic V, Wilske B, Schierz B, Pfister HW, Einhäupl KM (1984):
Repeated isolation of spirochetes from rhe cerebrospinal fluid of a patient with meningoradiculitis Bannwarth
Eur J Clin Microbiol, 1984, 3, 564-565

157. Rauer S, Kayser M, Neuber U, Rasiah C, Vogt A (1995):
Establishment of enzyme-linked immunosorbent assay using purified recombinant 83-kilodalton antigen of Borrelia burgdorferi sensu stricto and Borrelia afzelii for serodiagnosis of Lyme disease
J Clin Microbiol, 1995, 33, 10, 2596-2600

158. Rittig MG, Häupl T, Krause A, Kressel M, Groscurth P, Burmester GR (1997):
Borrelia burgdorferi-induced ultrastructural alterations in human phagocytes: a clue to pathogenicity?
J Pathol, 1997, 173, 269-282

159. Roberts WC, Mullikin BA, Lathigra R, Hanson MS (1998):
Molecular analysis of sequence heterogenitiy among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato
Infect Immun, 1998, 66, 11, 5275-5285

160. Robert-Koch-Institut (1996)
Lyme-Borreliose, Erkennung und Verhütung, Merkblatt für Ärzte
Robert-Koch-Institut und Bundesinstitut für gesundheitlichen Verbraucherschutz un Veterinärmedizin (Stand: 1996)

161. Rössler D, Eiffert H, Jauris-Heipke S, Lehnert G, Preac-Mursic V, Teepe J, Schlott T, Soutschek E, Wilske B (1995):
Molecular and immunological characterization of the p83/100 protein of various Borrelia burgdorferi sensu lato strains
Med Microbiol Immunol (Berl), 1995, 184, 1, 23-32

162. Rurainski und Partner
1-2 Minuten Info. Die Bedeutung des LTT in der Diagnostik der Borreliose

163. Sadziene A, Barbour AG, Rosa PA, Thomas DD (1993)
An ospB mutant of Borrelia burgdorferi has reduced invasivness in vitro and reduced infectivity in vivo
Infect Immun, 1993, 61, 3590-3596

164. Sadziene A, Thomas DD, Barbour AG (1995)
Borrelia burgdorferi mutant lacking osp: biological and immunological characterization
Infect Immun, 1995, 63, 1573-1580

165. Sadziene A, Wilske B, Ferdows MS, Barbour AG (1993):
The cryptic ospC gene of Borrelia burgdorferi B31 is located an a circular plasmid
Infect Immun, 1993, 61, 5, 2192-2195

166. Satz N (1993):
Klink der Lyme Borreliose
Verlag Hans Huber, Bern

167. Satz N (2002):
Klink der Lyme Borreliose
Verlag Hans Huber, Bern

168. Schutzer SE, Coyle PK, Brunner M (1992):
Specific serum immune complexes in Lyme disease
Abstr 135, p. A24. Program Abstr. 5th Int. Conf. Lyme Borreliosis

169. Schutzer SE, Coyle PK, Dunn JJ, Luft BJ, Brunner M (1994):
Early and specific antibody response to OspA in Lyme disease
J Clin Invest, 1994, 94, 1, 454-457

170. Schutzer SE, Coyle PK, Belman AL, Golightly MG, Drulle J (1990):
Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease
Lancet, 1990, 335, 312-315

171. Schwan T, Burgdorfer W (1987):
Antigenic changes of Borrelia burgdorferi as a result of in vitro cultivation
J Infect Dis, 1987, 156, 852-853

172. Shoemaker RC (2001):
Desperation medicine
Gateway Press, Inc Baltimore, MD

173. Sigal LH, Moffat CM, Steere AC, Dwyer J (1984):
Cellular immun findings in Lyme disease
Yale J Biol Med, 1984, 57, 595-598

174. Smith JL (1991):
Neuro-ocular Lyme borreliosis
Neurol Clin, 1991, 9, 1, 35-53

175. Steere AC, Gibofsy A, Patarroyo ME, Winchester RJ, Hardin JA, Malawista SE (1979):
Chronic Lyme arthritis: Clinical and immunogenetic differentiation from rheumaotoid arthritis
Ann Intern Med, 1979, 90, 286-291

176. Steere AC, Malawista SE, Newmann JH, Spieler PN, Bartenhagen NH (1980):
Antibiotic therapy in Lyme disease
Ann Intern Med, 1980, 93, 1-8

177. Steere AC (2001)
Lyme disease
N Engl J Med, 2001, 345, 2, 115-125

178. Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Pachner AR, Rahn DW, Sigal LH, Taylor E, Malawista SE (1986):
Clinical Feature – Overview. Clinical Manifestations of Lyme Disease
Zbl Bakt Hyg A, 1986, 263, 201-205

179. Steere AC, Batsford WP, Weinberg M, Alexander J, Berger HJ, Wolfson S, Malawista SE (1980):
Lyme carditis: cardiac abnormalities of Lyme disease
Ann Intern Med, 1980, 93, 8-16

180. Steere AC, Grodzicki RL, Kornblatt AN, Craft J, Barbour A, Burgdorfer W, Schmid GP, Johnson E, Malawista SE (1983):
The spirochetal ethology of Lyme disease
N Engl J Med, 1983, 308, 733-740

181. Steere AC, Gross D, Meyer AL, Huber BT (2001):
Autoimmune mechanisms in antibiotic treatment-resistant Lyme arthritis
J Autoimmun, 2001, 16, 3, 263-268

182. Steere AC, Malawista SE, Bartenhagen NH, Spieler PN, Newman JH, Rahn DW, Hutchinson GJ, Green J, Snydman DR, Taylor E (1984):
The clinical spectrum and treatment of Lyme disease
Yale J Biol Med, 1984, 57, 453-461

183. Stiernstedt G, Gustafsson R, Karlsson M, Svenungsson B, Skoldenberg B (1988):
Clinical manifestations and diagnosis of neuroborreliosis
Ann N Y Acad Sci, 1988, 539, 46-55

184. Strle F, Cheng Y, Cimperman J, Maraspin V, Lotric-Furlan S, Nelson JA, Picken MM, Ruzic-Sabljic E, Picken RN (1995):
Persistence of Borrelia burgdorferi sensu lato in resolved Erythema migrans lesions
Clin Infect Dis, 1995, 21, 380-389

185. Takayama K, Rothenberg RJ, Barbour AG (1987):
Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi
Infect Immun, 1987, 55, 2311-2313

186. Tylewska-Wierzbanowska S, Chielewski T (2002):
Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods
Wien Klin Wochenschrift, 2002, 114, 13-14, 601-605

187. Uegner KB, Duray P, Agricola M, Rosenkilde C, Yannuzzi LA, Ziska M, Tilton RC, Hulinska D, Hubbard J, Fallon BA (1997):
Lyme disease and the clinical spectrum of antibiotic responsive chronic meningoencephalomyelitidis
J spirochetal Tick-borne Dis, 1997, 4, 61-73

188. Vaz A, Glickstein L, Field JA, McHugh G, Sikand VK, Damle N, Steere AC (2001):
Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease
Infect Immun, 2001, 69, 12, 7437-7444

189. Wahlberg P, Granlund H, Nyman D, Panelius J, Seppala I (1993):
Late Lyme borreliosis: epidemiology, diagnosis and clinical features
Ann Med, 1993, 25, 4, 349-352

190. Wang G, van Dam AP, Schwartz I, Dankert J (1999):
Molecular typing of Borrelia burgdorferi sensu lato: axonomic, epidemiological and clinical implications
Clin Microbiol Rev, 1999, 12, 633-653

191. Weber K, Pfister HW (1994):
Clinical management of Lyme borreliosis
Lancet, 1994, 343, 8904, 1017-1020

192. Weber K, Wilske B, Matuschka FR, Pfister HW (1996):
Lyme borreliosis
Hautarzt, 1996, 47, 9, 724-733

193. Weyand CM, Goronzy JJ (1989):
Immune responses to Borrelia burgdorferi in patients with reactive arthritis
Arthritis Rheum, 1989, 32, 1057-1064

194. Whitmire WM, Garon CF (1993):
Infect Immun, 1993, 61, 1460-1467

195. Wienecke R, Zöchling N, Neubert U, Schülpen EM, Meurer M, Volkenandt M (1994):
Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans
J Invest Dermatol, 1994, 103, 19-22

196. Wilske B, Anderson HF, Baranton G, Barbour AG, Hovind-Hougen K, Johnson RC, Preac-Mursic V (1991):
Taxonomy of Borrelia spp.
Scand J Infect, 1991, 77, 108-129

197. Wilske B, Bader L, Pfister HW, Preac-Mursic V (1991):
Diagnosis of Lyme neuroborreliosis. Detection of intrathecal antibody formation
Fortschr Med, 1991, 109, 22, 441-446

198. Wilske B, Fingerle V, Herzer P, Hofmann A, Lehnert G, Peters H, Pfister HW, Preac-Mursic V, Soutschek E, Weber K (1993):
Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay
Med Microbiol Immunol (Berl), 1993, 182, 5, 255-270

199. Wilske B, Fingerle V, Herzer P, Pfister HW, Pohl-Koppe A, Weber K (2001):
Casus Med Lyme-Borreliose

200. Wilske B, Preac-Mursic V, Schierz G, Kühlbeck R, Barbour AG, Kramer M (1988):
Anitgenetic variability of B. burgdorferi
Ann NY Acad Sci, 1988, 539, 126-143

201. Wilske B, Schierz G, Preac Mursic V, Pfister HW, Weber K, von Busch K, Baruschke A (1989):
IgM- and IgG immune response to Borrelia burgdorferi in erythema migrans and neuroborreliosis
Zentralbl Bakteriol, 1989, 18, 290-298

202. Wilske B (1995):
Diagnostik der Borrelia-burgdorferi-Infektion
Internist, 1995, 36, 114-119

203. Wilske G, Preac-Mursic V, Jauris S, Hofmann A, Pradel I, Soutschek E, Schwab E, Will G, Wanner G (1993):
Immunological and Molecular Polymorphisms of OspC, an Immunodominant Major Outer Surface Protein of Borrelia burgdorferi
Infect Immun, 1993, 61, 5, 2182-2191

204. Yang L, Ma Y, Schoenfeld R, Griffiths M, Eichwald E, Araneo B, Weis JJ (1992):
Evidence for B-lymphozyte mitogen activity in Borrelia burgdorferi infected mice
Infect Immun, 1992, 60, 3033-3041

205. Yoshinari NH, Reinhardt BN, Steere AC (1991):
T cell responses to polypeptide fractions of borrelia burgdorferi in patients with lyme arthritis
Arthritis Rheum, 1991, 34, 6, 707-713

206. Zore A, Ruzic-Sabljic E, Maraspin V, Cimperman J, Lotric-Furlan S, Pikelj A, Jurca T, Logar M, Strle F (2002):
Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans,
Wien Klin Wochenschr, 2002, 114, 13-14, 606-609